RNA-targeting CRISPR reveals that hundreds of noncoding RNAs are essential—not 'junk'
Genes contain instructions for making proteins, and a central dogma of biology is that this information flows from DNA to RNA ...
Testing thousands of RNA enzymes helps find first 'twister ribozyme' in mammals
The "RNA world" hypothesis proposes that the earliest life on Earth may have been based on RNA—a single-stranded molecule ...
New Atlas3d
RNA therapy an effective alternative to lifelong, painful eye injections
An RNA-editing gene therapy has been developed that switches off the key driver of common eye conditions affecting diabetics ...
RNA editing promises to go where DNA editing can’t
On October 16, a biotechnology company in Massachusetts in the U.S. named Wave Life Sciences made headlines for becoming the ...
Tempus Publishes Study Highlighting Benefits of Concurrent RNA and DNA Sequencing in Advanced Cancer Care
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care ...
Discovery of a protein's key role in RNA processes could improve disease treatment in humans and plants
Texas A&M AgriLife researchers uncovered a promising target for controlling gene expression and other cellular processes, ...
Mitochondrial study offers new insights into how our cells process RNA for energy production
Researchers at the Department of Cell and Molecular Biology, Karolinska Institutet have made a major discovery in how human ...
Neuroscience News8d
RNA Structures Linked to Parkinson’s Protein Aggregates
Researchers have identified unique RNA structures called G-quadruplexes (G4s) that promote harmful α-synuclein protein ...
technologynetworks11d
New Mechanism Links RNA Structures to Parkinson’s Disease
A study from Kumamoto University reveals that G-quadruplex RNA structures facilitate the aggregation of α-synuclein, a ...
Business Wire11h
Arcturus Therapeutics Receives Clearance from FDA to Begin H5N1 Pandemic Flu Vaccine Clinical Trial
SAN DIEGO--(BUSINESS WIRE)--Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a commercial messenger RNA medicines company focused on the development of infectious disease ...
ProQR: Buy Rating Affirmed on Promising RNA Base-Editing Technology and Strong Financial Position
Keay Nakae, an analyst from Chardan Capital, maintained the Buy rating on ProQR (PRQR – Research Report). The associated price target is ...
Maravai Lifesciences to acquire DNA and RNA business of Officinae Bio
Maravai LifeSciences (MRVI) “announced that it has signed an agreement to acquire the DNA and RNA business of Officinae Bio. The ...